Search - tctmd.com

Displaying 681 - 700 of 2992

Sort: Relevancy | Date

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

Presentation TCT 2019

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Presenter: Azeem Latib

September 28, 2019

Presentation TCT 2019

Case 3: Diabetic Patient — Multivessel Disease With LM (2-Year IVUS Follow-Up)

Presenter: Prathap Kumar

September 28, 2019

Presentation TCT 2019

Is it TWILIGHT for Aspirin? Critical Appraisal and Interpretation of the Trial

Presenter: Pascal Vranckx

September 28, 2019

Presentation TCT 2019

Case 2: Abluminus in CHIP Cases and Outcomes

Presenter: Paolo Vicinelli

September 28, 2019

Presentation TCT 2019

Case 1: Step-by-Step Treatment Strategy of Complex Diabetic Patient With Abluminus DES

Presenter: Sameer Dani

September 28, 2019

Presentation TCT 2019

My Strategy for Interpreting (And Critiquing) Non-Inferiority Studies

Presenter: Sanjay Kaul

September 28, 2019

Presentation TCT 2019

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

Presenter: Roxana Mehran

September 28, 2019

Presentation TCT 2019

LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Presenter: Kenneth Ouriel

September 28, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

The Challenges of Equipoise and Generalizability

Presenter: Robert Yeh

September 28, 2019

Presentation TCT 2019

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presenter: Milton Packer

September 28, 2019

Presentation TCT 2019

Use of Repeat Events and Allowance for Competing Risk: How to Do It Right

Presenter: Andrew Althouse

September 28, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

Presentation TCT 2019

Sirolimus-Coated Balloon for the Treatment of Vasculogenic Erectile Dysfunction: Ready for the Prime Time

Presenter: Giuseppe Sangiorgi

September 28, 2019

Presentation TCT 2019

Data Considerations Beyond Stent Expansion Limits. Not All Stents are Created Equal

Presenter: Nick West

September 28, 2019

Presentation TCT 2019

The Early Days of Coronary Stenting: A Tribute to Charles Dotter

Presenter: Philippe Gaspard

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

Presentation TCT 2019

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Presenter: Sreekala Padmanabhan

September 28, 2019

Advertisement

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Case 3: Diabetic Patient — Multivessel Disease With LM (2-Year IVUS Follow-Up)

Is it TWILIGHT for Aspirin? Critical Appraisal and Interpretation of the Trial

Case 2: Abluminus in CHIP Cases and Outcomes

Case 1: Step-by-Step Treatment Strategy of Complex Diabetic Patient With Abluminus DES

My Strategy for Interpreting (And Critiquing) Non-Inferiority Studies

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

The Challenges of Equipoise and Generalizability

When Trials Disagree: The COAPT/MITRA-FR Case Study

Use of Repeat Events and Allowance for Competing Risk: How to Do It Right

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Sirolimus-Coated Balloon for the Treatment of Vasculogenic Erectile Dysfunction: Ready for the Prime Time

Data Considerations Beyond Stent Expansion Limits. Not All Stents are Created Equal

The Early Days of Coronary Stenting: A Tribute to Charles Dotter

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content